Financial Performance Expectations - The company expects a net profit attributable to shareholders of the parent company for 2024 to be between -69 million and -103.5 million yuan, indicating a loss compared to the previous year [3]. - The net profit attributable to shareholders after deducting non-recurring gains and losses is projected to be between -90 million and -124.5 million yuan [3]. - The previous year's net profit attributable to shareholders was -119.27 million yuan, with a net profit after deducting non-recurring gains and losses of -311.82 million yuan [6]. Reasons for Expected Loss - The main reasons for the expected loss include the underperformance of the medical services segment and lower coal production due to regulatory issues [7]. - The medical services segment is still in its early operational phase, leading to high costs and low revenue [7]. - The coal business faced challenges due to gas exceedance rectification and personnel restructuring, resulting in lower-than-expected coal production [7]. Non-Operating Gains and Risks - Non-operating gains include government subsidies amounting to 25.44 million yuan [7]. - The company warns of potential risks related to market price fluctuations of key chemical products and inventory valuation issues [8]. Financial Data and Investor Caution - The preliminary financial data is subject to change and has not been audited by registered accountants [9]. - Investors are advised to be cautious as the final audited financial report may differ from the preliminary estimates [10].
赤天化(600227) - 2024 Q4 - 年度业绩预告